Will, Yvonne
Crinetics Pharmaceuticals, Inc.,
United States
2025 Rank: 290399
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1153 out of 67220 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 290399 | 331661 |
| Total Cites | 383 | 403 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 37 | 37 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 234 | 238 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 339 | 350 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
4.96%
|
|
Will, Yvonne
Crinetics Pharmaceuticals, Inc.,
United States
2024 Rank: 192965
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 796 out of 65055 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 192965 | 208490 |
| Total Cites | 434 | 470 |
| H-index | 11 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 52 | 56 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 300 | 321 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 341 | 357 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
7.66%
|
|
Will, Yvonne
Janssen Research & Development,
Belgium
2023 Rank: 206685
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 877 out of 61487 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 206685 | 231369 |
| Total Cites | 426 | 438 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 44 | 44 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 301 | 305 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 338 | 343 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
2.74%
|
|
Will, Yvonne
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2022 Rank: 133192
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 547 out of 55990 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133192 | 143619 |
| Total Cites | 438 | 463 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 49 | 50 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 313 | 325 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 359 | 374 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
5.40%
|
|
Will, Yvonne
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2021 Rank: 121598
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 505 out of 53247 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121598 | 131062 |
| Total Cites | 670 | 723 |
| H-index | 16 | 17 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 68 | 71 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 482 | 510 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 529 | 555 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.30 |
| Self-Citation Percentage |
7.33%
|
|
Will, Yvonne
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2020 Rank: 131014
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 575 out of 45124 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131014 | 132488 |
| Total Cites | 517 | 598 |
| H-index | 14 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 45 | 48 |
| Number of Single+First+Last Authored Papers | 58 | 58 |
| Total Cites to Single+First+Last Authored Papers | 394 | 450 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 422 | 442 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.35 |
| Self-Citation Percentage |
13.55%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.